XELOXIRI
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for XELOXIRI, covering 2020-05-08 to 2020-05-08. Get the full timeline:
Most recent: Clinical Trial Update: A Phase I/II Study of XELOXIRI and Bevacizumab as First-line Treatment in Metastatic Colorectal Cancer [Phase 1, Phase 2]